Edition:
United Kingdom

Cellectar Biosciences Inc (CLRB.OQ)

CLRB.OQ on NASDAQ Stock Exchange Capital Market

1.94USD
5:16pm BST
Change (% chg)

$-0.03 (-1.52%)
Prev Close
$1.97
Open
$1.94
Day's High
$1.94
Day's Low
$1.81
Volume
67,829
Avg. Vol
79,546
52-wk High
$12.76
52-wk Low
$1.22

About

Cellectar Biosciences, Inc., formerly Novelos Therapeutics, Inc., is a clinical stage biopharmaceutical company. The Company is engaged in developing phospholipid ether-drug conjugates (PDCs) for the treatment and diagnostic imaging of cancer. Its research and development program is based on its PDC cancer targeting delivery... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $23.88
Shares Outstanding(Mil.): 13.92
Dividend: --
Yield (%): --

Financials

  CLRB.OQ Industry Sector
P/E (TTM): -- 29.30 32.55
EPS (TTM): -1.24 -- --
ROI: -103.68 14.23 13.82
ROE: -105.20 15.46 15.24

Earnings vs. Estimates